Terms: = Ovarian cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
929 results:
1. VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/erk signaling pathway.
Wang Q; Tang Y; Dai A; Li T; Pei Y; Zhang Z; Hu X; Chen T; Chen Q
Appl Microbiol Biotechnol; 2024 Feb; 108(1):218. PubMed ID: 38372808
[TBL] [Abstract] [Full Text] [Related]
2. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/erk pathway.
Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
[TBL] [Abstract] [Full Text] [Related]
3. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in ovarian cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract] [Full Text] [Related]
4. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract] [Full Text] [Related]
5. Bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/8 signaling in human granulosa-lutein cells.
Liu B; Fu B; Zhou S; Wang H; Bi B; Guo M; Cheng JC; Fang L
Mol Cell Endocrinol; 2024 Mar; 582():112126. PubMed ID: 38109991
[TBL] [Abstract] [Full Text] [Related]
6. Immune Modulation of Innate and Adaptive Responses Restores Immune Surveillance and Establishes Antitumor Immunologic Memory.
Alvero AB; Fox A; Madina BR; Krady MM; Gogoi R; Chehade H; Nakaar V; Almassian B; Yarovinsky TO; Rutherford T; Mor G
Cancer Immunol Res; 2024 Feb; 12(2):261-274. PubMed ID: 38078853
[TBL] [Abstract] [Full Text] [Related]
7. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.
Cook DP; Galpin KJC; Rodriguez GM; Shakfa N; Wilson-Sanchez J; Echaibi M; Pereira M; Matuszewska K; Haagsma J; Murshed H; Cudmore AO; MacDonald E; Tone A; Shepherd TG; Petrik JJ; Koti M; Vanderhyden BC
Commun Biol; 2023 Nov; 6(1):1152. PubMed ID: 37957414
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
[TBL] [Abstract] [Full Text] [Related]
9. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
10. Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Luo Y; Shreeder B; Jenkins JW; Shi H; Lamichhane P; Zhou K; Bahr DA; Kurian S; Jones KA; Daum JI; Dutta N; Necela BM; Cannon MJ; Block MS; Knutson KL
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37918918
[TBL] [Abstract] [Full Text] [Related]
11. Targeting RAS-erk pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.
Nguyen NT; Raetz A; Montoya D; Schilling V; Tong C; Brooks RA; Leiserowitz G; Chien J
Gynecol Oncol; 2023 Nov; 178():69-79. PubMed ID: 37806229
[TBL] [Abstract] [Full Text] [Related]
12. Dicalcin suppresses invasion and metastasis of mammalian ovarian cancer cells by regulating the ganglioside-erk1/2 axis.
Miwa N; Hanaue M; Aoba K; Saito R; Takamatsu K
Commun Biol; 2023 Oct; 6(1):1015. PubMed ID: 37803211
[TBL] [Abstract] [Full Text] [Related]
13. A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
Kim ES; Kim S; Moon A
Oncol Res; 2023; 31(6):867-875. PubMed ID: 37744269
[TBL] [Abstract] [Full Text] [Related]
14. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/erk/STAT3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract] [Full Text] [Related]
15. CC Chemokine 2 Promotes ovarian cancer Progression through the MEK/erk/MAP3K19 Signaling Pathway.
Liu W; Wang L; Zhang J; Cheng K; Zheng W; Ma Z
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445830
[TBL] [Abstract] [Full Text] [Related]
16. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
17. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
18. HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/erk signaling pathway.
Ma H; Qi G; Han F; Gai P; Peng J; Kong B
Cell Commun Signal; 2023 Jun; 21(1):144. PubMed ID: 37328851
[TBL] [Abstract] [Full Text] [Related]
19. A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting perk as regulator of apoptosis.
König P; Zhulenko R; Suparman E; Hoffmeister H; Bückreiß N; Ott I; Bendas G
Cancer Chemother Pharmacol; 2023 Jul; 92(1):57-69. PubMed ID: 37272932
[TBL] [Abstract] [Full Text] [Related]
20. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract] [Full Text] [Related]
[Next]
